Shyam Kambeyanda
Net Worth
Last updated:
What is Shyam Kambeyanda net worth?
The estimated net worth of Mr. Shyam Kambeyanda is at least $38,682,371 as of 26 Sep 2025. He owns shares worth $17,265,793 as insider, has earned $6,836,578 from insider trading and has received compensation worth at least $14,580,000 in companies like Enovis Corporation, Colfax Corporation, Colfax Corporation etc.
What is the salary of Shyam Kambeyanda?
Mr. Shyam Kambeyanda salary is $1,260,000 per year as Executive Vice President and Chief Executive Officer & Pres of ESAB in Enovis Corporation. He also receives $1,110,000 as Executive Vice President and Chief Executive Officer & Pres of ESAB in Colfax Corporation and salaries from other companies.
How old is Shyam Kambeyanda?
Mr. Shyam Kambeyanda is 54 years old, born in 1971.
What stocks does Shyam Kambeyanda currently own?
As insider, Mr. Shyam Kambeyanda owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Colfax Corporation (CFX) | Executive Vice President and Chief Executive Officer & Pres of ESAB | 100,985 | $39.06 | $3,944,474 |
| Colfax Corporation (CFXA) | Executive Vice President and Chief Executive Officer & Pres of ESAB | 74,961 | $177.71 | $13,321,319 |
What does Colfax Corporation do?
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
What does Colfax Corporation do?
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
Shyam Kambeyanda insider trading
Colfax Corporation
Mr. Shyam Kambeyanda has made 13 insider trades between 2018-2022, according to the Form 4 filled with the SEC. Most recently he sold 2,788 units of CFX stock worth $108,397 on 7 Mar 2022.
The largest trade he's ever made was exercising 39,862 units of CFX stock on 15 Oct 2021. As of 26 Sep 2025 he still owns at least 100,985 units of CFX stock.
Colfax Corporation
Mr. Shyam Kambeyanda has made 5 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 2,366 units of CFXA stock worth $104,885 on 14 Dec 2021.
The largest trade he's ever made was exercising 39,862 units of CFXA stock on 15 Oct 2021. As of 26 Sep 2025 he still owns at least 74,961 units of CFXA stock.
Enovis key executives
Enovis Corporation executives and other stock owners filed with the SEC:
- Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec.
- Mr. Brady R. Shirley (59) Chief Executive Officer of DJO & Executive Vice President
- Mr. Christopher M. Hix (63) Executive Vice President of Fin. & Chief Financial Officer
- Mr. Daniel A. Pryor (57) Executive Vice President of Strategy & Bus. Devel.
- Mr. Matthew L. Trerotola (58) Pres, Chief Executive Officer & Director
- Mr. Mitchell P. Rales (68) Co-Founder & Chairman
- Mr. Shyam Kambeyanda (54) Executive Vice President and Chief Executive Officer & Pres of ESAB
- Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas
- Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel.
- Ms. Patricia A. Lang Senior Vice President & Chief HR Officer